Bihua Chen - Net Worth and Insider Trading
Bihua Chen Net Worth
The estimated net worth of Bihua Chen is at least $423 Million dollars as of 2024-05-04. Bihua Chen is the 10% Owner of MoonLake Immunotherapeutics and owns about 8,494,151 shares of MoonLake Immunotherapeutics (MLTX) stock worth over $384 Million. Bihua Chen is the Director of Erasca Inc and owns about 10,813,246 shares of Erasca Inc (ERAS) stock worth over $23 Million. Bihua Chen is also the CEO and Chairperson, 10% Owner of Helix Acquisition Corp II and owns about 903,600 shares of Helix Acquisition Corp II (HLXB) stock worth over $9 Million. Besides these, Bihua Chen also holds Helix Acquisition Corp (HLXA) . Details can be seen in Bihua Chen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Bihua Chen has not made any transactions after 2024-02-13 and currently still holds the listed stock(s).
Transaction Summary of Bihua Chen
Bihua Chen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bihua Chen owns 37 companies in total, including Helix Acquisition Corp (HLXA) , Akouos Inc (AKUS) , and Avidity Biosciences Inc (RNA) among others .
Click here to see the complete history of Bihua Chen’s form 4 insider trades.
Insider Ownership Summary of Bihua Chen
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HLXA | Helix Acquisition Corp | 2020-10-22 | director & 10 percent owner & CEO and Chairman |
AKUS | Akouos Inc | 2020-06-25 | director & 10 percent owner |
RNA | Avidity Biosciences Inc | 2020-06-11 | director & 10 percent owner |
2019-04-22 | director & 10 percent owner | ||
2018-10-30 | director & 10 percent owner | ||
2018-07-18 | director & 10 percent owner | ||
2018-06-20 | director & 10 percent owner | ||
2018-05-23 | director & 10 percent owner | ||
2017-12-14 | director & 10 percent owner | ||
2017-11-08 | director & 10 percent owner | ||
2016-06-01 | director & 10 percent owner | ||
2014-08-15 | director & 10 percent owner | ||
2016-11-03 | director & 10 percent owner | ||
2020-10-29 | director & 10 percent owner | ||
2021-03-11 | director & 10 percent owner | ||
2021-04-22 | director & 10 percent owner | ||
2020-11-18 | director & 10 percent owner | ||
2022-12-20 | director | ||
2021-10-07 | 10 percent owner | ||
2021-06-24 | 10 percent owner | ||
2021-07-28 | 10 percent owner | ||
2023-04-20 | 10 percent owner | ||
2021-06-29 | 10 percent owner | ||
2021-03-25 | director & 10 percent owner | ||
2023-10-05 | 10 percent owner | ||
2021-06-23 | director & 10 percent owner | ||
2020-12-15 | director & 10 percent owner | ||
2022-01-06 | 10 percent owner | ||
2023-03-30 | director & 10 percent owner | ||
2021-06-16 | director & 10 percent owner | ||
2021-10-20 | 10 percent owner | ||
2021-09-14 | 10 percent owner | ||
2016-11-03 | director & 10 percent owner | ||
2023-03-03 | 10 percent owner | ||
2023-05-29 | other: See below | ||
2023-05-29 | other: See below | ||
2023-10-23 | 10 percent owner |
Bihua Chen Latest Holdings Summary
Bihua Chen currently owns a total of 4 stocks. Among these stocks, Bihua Chen owns 8,494,151 shares of MoonLake Immunotherapeutics (MLTX) as of October 5, 2023, with a value of $384 Million and a weighting of 90.97%. Bihua Chen owns 10,813,246 shares of Erasca Inc (ERAS) as of December 13, 2022, with a value of $23 Million and a weighting of 5.48%. Bihua Chen also owns 903,600 shares of Helix Acquisition Corp II (HLXB) as of February 13, 2024, with a value of $9 Million and a weighting of 2.21%. The other 1 stocks Helix Acquisition Corp (HLXA) have a combined weighting of 1.35% among all his current holdings.
Latest Holdings of Bihua Chen
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MLTX | MoonLake Immunotherapeutics | 2023-10-05 | 8,494,151 | 45.26 | 384,445,274 |
ERAS | Erasca Inc | 2022-12-13 | 10,813,246 | 2.14 | 23,140,346 |
HLXB | Helix Acquisition Corp II | 2024-02-13 | 903,600 | 10.34 | 9,343,224 |
HLXA | Helix Acquisition Corp | 2020-10-22 | 430,000 | 13.25 | 5,697,500 |
Holding Weightings of Bihua Chen
Bihua Chen Form 4 Trading Tracker
According to the SEC Form 4 filings, Bihua Chen has made a total of 5 transactions in MoonLake Immunotherapeutics (MLTX) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in MoonLake Immunotherapeutics is the acquisition of 58,839 shares on October 5, 2023, which cost Bihua Chen around $4 Million.
According to the SEC Form 4 filings, Bihua Chen has made a total of 4 transactions in Erasca Inc (ERAS) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Erasca Inc is the acquisition of 307,692 shares on December 13, 2022, which cost Bihua Chen around $2 Million.
According to the SEC Form 4 filings, Bihua Chen has made a total of 1 transactions in Helix Acquisition Corp II (HLXB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Helix Acquisition Corp II is the acquisition of 2,400,000 shares on February 13, 2024, which cost Bihua Chen around $24 Million.
More details on Bihua Chen's insider transactions can be found in the Insider Trading History of Bihua Chen table.Insider Trading History of Bihua Chen
- 1
Bihua Chen Trading Performance
GuruFocus tracks the stock performance after each of Bihua Chen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bihua Chen is -5.87%. GuruFocus also compares Bihua Chen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bihua Chen within 3 months outperforms 2 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bihua Chen's insider trading performs compared to the benchmark.
Bihua Chen Ownership Network
Bihua Chen Owned Company Details
What does Helix Acquisition Corp do?
Who are the key executives at Helix Acquisition Corp?
Bihua Chen is the director & 10 percent owner & CEO and Chairman of Helix Acquisition Corp. Other key executives at Helix Acquisition Corp include director & 10 percent owner Helix Holdings Llc , and Chief Financial Officer Jay Scollins .
Helix Acquisition Corp (HLXA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp (HLXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp (HLXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Helix Acquisition Corp (HLXA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Helix Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Akouos Inc do?
Who are the key executives at Akouos Inc?
Bihua Chen is the director & 10 percent owner of Akouos Inc. Other key executives at Akouos Inc include 10 percent owner Kearny Acquisition Corp , 10 percent owner Lilly Eli & Co , and Chief Operating Officer Jennifer Anne Wellman .
Akouos Inc (AKUS) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Akouos Inc (AKUS). Other recent insider transactions involving Akouos Inc (AKUS) include a net purchase of 29,992,668 shares made by Kearny Acquisition Corp ,
In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 29,992,668 shares were bought by its insiders, resulting in a net purchase of 29,992,668 shares.
Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Akouos Inc Insider Transactions
- Download to Excel(.xls)
What does Avidity Biosciences Inc do?
Who are the key executives at Avidity Biosciences Inc?
Bihua Chen is the director & 10 percent owner of Avidity Biosciences Inc. Other key executives at Avidity Biosciences Inc include Chief Scientific Officer Arthur A Levin , director & President and CEO Sarah Boyce , and Chief Financial Officer Michael F Maclean .
Avidity Biosciences Inc (RNA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 119,600 shares made by Arthur A Levin , a net sale of 195,092 shares made by Sarah Boyce , and a net sale of 41,616 shares made by Michael F Maclean .
In summary, during the past 3 months, insiders sold 237,641 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 237,641 shares. During the past 18 months, 362,502 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 362,502 shares.
Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avidity Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Turning Point Therapeutics Inc do?
Who are the key executives at Turning Point Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .
Turning Point Therapeutics Inc (TPTX) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Turning Point Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Axonics Inc do?
Who are the key executives at Axonics Inc?
Bihua Chen is the director & 10 percent owner of Axonics Inc. Other key executives at Axonics Inc include Chief Financial Officer Kari Leigh Keese , Chief Medical Officer Karen Noblett , and director & Chief Executive Officer Raymond W Cohen .
Axonics Inc (AXNX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 66,432 shares made by Danny L. Dearen , a net sale of 78,838 shares made by Ford Alfred J Jr , and a net sale of 39,921 shares made by Karen Noblett .
In summary, during the past 3 months, insiders sold 0 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 397,082 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 397,082 shares.
Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axonics Inc Insider Transactions
- Download to Excel(.xls)
What does Constellation Pharmaceuticals Inc do?
Who are the key executives at Constellation Pharmaceuticals Inc?
Bihua Chen is the director & 10 percent owner of Constellation Pharmaceuticals Inc. Other key executives at Constellation Pharmaceuticals Inc include Chief Financial Officer Emma Reeve , 10 percent owner Column Group L P , and See Remarks Karen Valentine .
Constellation Pharmaceuticals Inc (CNST) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Constellation Pharmaceuticals Inc (CNST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Constellation Pharmaceuticals Inc (CNST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Constellation Pharmaceuticals Inc (CNST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Constellation Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Kezar Life Sciences Inc do?
Who are the key executives at Kezar Life Sciences Inc?
Bihua Chen is the director & 10 percent owner of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .
Kezar Life Sciences Inc (KZR) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 508,747 shares made by Morningside Venture Investments Ltd ,
In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 508,747 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 508,747 shares.
Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kezar Life Sciences Inc Insider Transactions
- Download to Excel(.xls)
What does Kiniksa Pharmaceuticals Ltd do?
Who are the key executives at Kiniksa Pharmaceuticals Ltd?
Bihua Chen is the director & 10 percent owner of Kiniksa Pharmaceuticals Ltd. Other key executives at Kiniksa Pharmaceuticals Ltd include director & 10 percent owner & Chairman & CEO Sanj K Patel , Chief Accounting Officer Michael R Megna , and Chief Medical Officer John Paolini .
Kiniksa Pharmaceuticals Ltd (KNSA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Kiniksa Pharmaceuticals Ltd (KNSA). Other recent insider transactions involving Kiniksa Pharmaceuticals Ltd (KNSA) include a net sale of 96,513 shares made by John Paolini , a net sale of 83,336 shares made by Sanj K Patel , and a net sale of 24,101 shares made by Michael R Megna .
In summary, during the past 3 months, insiders sold 108,277 shares of Kiniksa Pharmaceuticals Ltd (KNSA) in total and bought 0 shares, with a net sale of 108,277 shares. During the past 18 months, 225,909 shares of Kiniksa Pharmaceuticals Ltd (KNSA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 225,909 shares.
Kiniksa Pharmaceuticals Ltd (KNSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kiniksa Pharmaceuticals Ltd Insider Transactions
- Download to Excel(.xls)
What does Proteostasis Therapeutics Inc do?
Who are the key executives at Proteostasis Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include Interim Head of Finance Michael Alfieri , director & President and CEO Meenu Chhabra , and See Remarks Eric D Larson .
Proteostasis Therapeutics Inc (PTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Proteostasis Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Bihua Chen is the director & 10 percent owner of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include Chief Operating Officer Pascal Deschatelets , Chief Financial Officer Timothy Eugene Sullivan , and Senior Vice President Mark Jeffrey Delong .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 301,781 shares made by Pascal Deschatelets , a net sale of 16,250 shares made by Alec Machiels , and a net sale of 551,287 shares made by Cedric Francois .
In summary, during the past 3 months, insiders sold 441,279 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 441,279 shares. During the past 18 months, 1,343,452 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,343,452 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Clearside Biomedical Inc do?
Who are the key executives at Clearside Biomedical Inc?
Bihua Chen is the director & 10 percent owner of Clearside Biomedical Inc. Other key executives at Clearside Biomedical Inc include 10 percent owner Bradford T Whitmore , Chief Financial Officer Charles A. Deignan , and director & 10 percent owner Clay Thorp .
Clearside Biomedical Inc (CLSD) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Clearside Biomedical Inc (CLSD). Other recent insider transactions involving Clearside Biomedical Inc (CLSD) include a net purchase of 580,222 shares made by Bradford T Whitmore , a net purchase of 40,000 shares made by Nancy J Hutson , and a net sale of 38,030 shares made by George M Lasezkay .
In summary, during the past 3 months, insiders sold 0 shares of Clearside Biomedical Inc (CLSD) in total and bought 574,444 shares, with a net purchase of 574,444 shares. During the past 18 months, 80,830 shares of Clearside Biomedical Inc (CLSD) were sold and 774,222 shares were bought by its insiders, resulting in a net purchase of 693,392 shares.
Clearside Biomedical Inc (CLSD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Clearside Biomedical Inc Insider Transactions
- Download to Excel(.xls)
What does Cellectar Biosciences Inc do?
Who are the key executives at Cellectar Biosciences Inc?
Bihua Chen is the director & 10 percent owner of Cellectar Biosciences Inc. Other key executives at Cellectar Biosciences Inc include Senior Vice President & Medical Andrei Shustov , Chief Commercial Officer Darrell Shane Lea , and Chief Financial Officer Chad J Kolean .
Cellectar Biosciences Inc (CLRB) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cellectar Biosciences Inc (CLRB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cellectar Biosciences Inc (CLRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cellectar Biosciences Inc (CLRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cellectar Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Yumanity Therapeutics Inc do?
Who are the key executives at Yumanity Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Yumanity Therapeutics Inc. Other key executives at Yumanity Therapeutics Inc include director & Chief Executive Officer Shawn Iadonato , Chief Scientific Officer Thierry Guillaudeux , and Chief Financial Officer Keith Baker .
Yumanity Therapeutics Inc (YMTX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Yumanity Therapeutics Inc (YMTX). Other recent insider transactions involving Yumanity Therapeutics Inc (YMTX) include a net sale of 10,890 shares made by Richard Peters , a net sale of 3,116 shares made by Michael D Wyzga , and a net sale of 3,116 shares made by Devin Whittemore Smith .
In summary, during the past 3 months, insiders sold 0 shares of Yumanity Therapeutics Inc (YMTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 19,098 shares of Yumanity Therapeutics Inc (YMTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 19,098 shares.
Yumanity Therapeutics Inc (YMTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Yumanity Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Atea Pharmaceuticals Inc do?
Who are the key executives at Atea Pharmaceuticals Inc?
Bihua Chen is the director & 10 percent owner of Atea Pharmaceuticals Inc. Other key executives at Atea Pharmaceuticals Inc include See Remarks Andrea Corcoran , See Remarks Wayne Foster , and director & 10 percent owner & President & CEO & and Chairman Jean-pierre Sommadossi .
Atea Pharmaceuticals Inc (AVIR) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 56,910 shares made by Jean-pierre Sommadossi , a net sale of 41,666 shares made by Franklin M Berger , and a net sale of 15,870 shares made by Maria Arantxa Horga .
In summary, during the past 3 months, insiders sold 0 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 168,614 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 168,614 shares.
Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atea Pharmaceuticals Inc Insider Transactions
- Download to Excel(.xls)
What does Prometheus Biosciences Inc do?
Who are the key executives at Prometheus Biosciences Inc?
Bihua Chen is the director & 10 percent owner of Prometheus Biosciences Inc. Other key executives at Prometheus Biosciences Inc include Chief Financial Officer Keith W Marshall , director & President and CEO Mark C. Mckenna , and 10 percent owner Cedars Sinai Intellectual Property Co .
Prometheus Biosciences Inc (RXDX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Prometheus Biosciences Inc (RXDX). Other recent insider transactions involving Prometheus Biosciences Inc (RXDX) include a net sale of 125,000 shares made by Mark C. Mckenna , a net sale of 30,000 shares made by Keith W Marshall , and a net sale of 865,000 shares made by Cedars Sinai Intellectual Property Co .
In summary, during the past 3 months, insiders sold 0 shares of Prometheus Biosciences Inc (RXDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,020,000 shares of Prometheus Biosciences Inc (RXDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,020,000 shares.
Prometheus Biosciences Inc (RXDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Prometheus Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Rain Oncology Inc do?
Who are the key executives at Rain Oncology Inc?
Bihua Chen is the director & 10 percent owner of Rain Oncology Inc. Other key executives at Rain Oncology Inc include 10 percent owner Kevin C Tang , Principal Fin. & Acc. Officer Josephine Bruce , and 10 percent owner Tang Capital Management Llc .
Rain Oncology Inc (RAIN) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net purchase of 1,710,358 shares made by Biotechnology Value Fund L P .
In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 3,247,657 shares were bought by its insiders, resulting in a net purchase of 2,078,684 shares.
Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Rain Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Olema Pharmaceuticals inc do?
Who are the key executives at Olema Pharmaceuticals inc?
Bihua Chen is the director & 10 percent owner of Olema Pharmaceuticals inc. Other key executives at Olema Pharmaceuticals inc include director & Chief Technology Officer Cyrus Harmon , 10 percent owner Paradigm Biocapital Advisors Lp , and director & President and CEO Sean Bohen .
Olema Pharmaceuticals inc (OLMA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 278,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .
In summary, during the past 3 months, insiders sold 60,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 60,000 shares. During the past 18 months, 413,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 1,842,858 shares.
Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Olema Pharmaceuticals inc Insider Transactions
- Download to Excel(.xls)
What does Erasca Inc do?
Who are the key executives at Erasca Inc?
Bihua Chen is the director of Erasca Inc. Other key executives at Erasca Inc include director & 10 percent owner & See Remarks Jonathan E Lim , Chief Medical Officer Shannon Morris , and General Counsel Ebun Garner .
Erasca Inc (ERAS) Insider Trades Summary
Over the past 18 months, Bihua Chen made 2 insider transaction in Erasca Inc (ERAS) with a net purchase of 615,384. Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,300,000 shares made by Jonathan E Lim , a net purchase of 70,000 shares made by Alexander W. Casdin , and a net purchase of 20,000 shares made by Start Valerie Denise Harding .
In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 3,025,384 shares were bought by its insiders, resulting in a net purchase of 3,025,384 shares.
Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Erasca Inc Insider Transactions
- Download to Excel(.xls)
What does Pyxis Oncology Inc do?
Who are the key executives at Pyxis Oncology Inc?
Bihua Chen is the 10 percent owner of Pyxis Oncology Inc. Other key executives at Pyxis Oncology Inc include Chief Financial Officer Pamela Ann Connealy , Chief Accounting Officer Jitendra Wadhane , and director & Chief Executive Officer Lara Sullivan .
Pyxis Oncology Inc (PYXS) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Pyxis Oncology Inc (PYXS). Other recent insider transactions involving Pyxis Oncology Inc (PYXS) include a net purchase of 31,426 shares made by Pamela Ann Connealy , a net purchase of 10,000 shares made by Jitendra Wadhane , and a net purchase of 3,623,188 shares made by Pfizer Inc .
In summary, during the past 3 months, insiders sold 0 shares of Pyxis Oncology Inc (PYXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,558 shares of Pyxis Oncology Inc (PYXS) were sold and 3,664,614 shares were bought by its insiders, resulting in a net purchase of 3,628,056 shares.
Pyxis Oncology Inc (PYXS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pyxis Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Elevation Oncology Inc do?
Who are the key executives at Elevation Oncology Inc?
Bihua Chen is the 10 percent owner of Elevation Oncology Inc. Other key executives at Elevation Oncology Inc include CHIEF FINANCIAL OFFICER Tammy Furlong , 10 percent owner Venbio Global Strategic Gp Iii, L.p. , and 10 percent owner Venbio Global Strategic Fund Iii, L.p. .
Elevation Oncology Inc (ELEV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Elevation Oncology Inc (ELEV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elevation Oncology Inc (ELEV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Elevation Oncology Inc (ELEV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elevation Oncology Inc Insider Transactions
- Download to Excel(.xls)
What does Icosavax Inc do?
Who are the key executives at Icosavax Inc?
Bihua Chen is the 10 percent owner of Icosavax Inc. Other key executives at Icosavax Inc include director & Chief Executive Officer Adam K. Simpson , Chief Medical Officer Niranjan Kanesa-thasan , and Chief Financial Officer Thomas Joseph Russo .
Icosavax Inc (ICVX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Icosavax Inc (ICVX). Other recent insider transactions involving Icosavax Inc (ICVX) include a net sale of 268,263 shares made by Adam K. Simpson , a net sale of 35,241 shares made by Cassia Cearley , and a net sale of 123,374 shares made by Niranjan Kanesa-thasan .
In summary, during the past 3 months, insiders sold 0 shares of Icosavax Inc (ICVX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 514,269 shares of Icosavax Inc (ICVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 514,269 shares.
Icosavax Inc (ICVX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Icosavax Inc Insider Transactions
- Download to Excel(.xls)
What does Immuneering Corp do?
Who are the key executives at Immuneering Corp?
Bihua Chen is the 10 percent owner of Immuneering Corp. Other key executives at Immuneering Corp include 10 percent owner Cormorant Asset Management, Lp , Vice President & Finance Mallory Morales , and Chief Business Officer Harold Eugene Brakewood .
Immuneering Corp (IMRX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Immuneering Corp (IMRX). Other recent insider transactions involving Immuneering Corp (IMRX) include a net sale of 1,309,091 shares made by Cormorant Asset Management, Lp , a net purchase of 100,000 shares made by Peter Feinberg , and a net purchase of 57,965 shares made by Ann E Berman .
In summary, during the past 3 months, insiders sold 1,309,091 shares of Immuneering Corp (IMRX) in total and bought 197,083 shares, with a net sale of 1,112,008 shares. During the past 18 months, 1,309,091 shares of Immuneering Corp (IMRX) were sold and 197,083 shares were bought by its insiders, resulting in a net sale of 1,112,008 shares.
Immuneering Corp (IMRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immuneering Corp Insider Transactions
- Download to Excel(.xls)
What does Aerovate Therapeutics Inc do?
Who are the key executives at Aerovate Therapeutics Inc?
Bihua Chen is the 10 percent owner of Aerovate Therapeutics Inc. Other key executives at Aerovate Therapeutics Inc include SENIOR VICE PRESIDENT & CMC Marinus Verwijs , director & Chief Executive Officer Timothy P Noyes , and See Remarks Benjamin T Dake .
Aerovate Therapeutics Inc (AVTE) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 283,585 shares made by Benjamin T Dake , a net sale of 143,142 shares made by Timothy P Noyes , and a net sale of 58,255 shares made by Hunter Gillies .
In summary, during the past 3 months, insiders sold 203,125 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 203,125 shares. During the past 18 months, 649,019 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 649,019 shares.
Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aerovate Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Design Therapeutics Inc do?
Who are the key executives at Design Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Design Therapeutics Inc. Other key executives at Design Therapeutics Inc include director & President and CEO Joao Md Siffert , director & 10 percent owner Simeon George , and 10 percent owner Sr One Capital Fund I Aggregator Lp .
Design Therapeutics Inc (DSGN) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 36,000 shares made by Rodney W Lappe , a net purchase of 2,235,000 shares made by Arsani William , and a net purchase of 900,000 shares made by Sr One Capital Fund I Aggregator Lp .
In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 28,265 shares, with a net purchase of 28,265 shares. During the past 18 months, 0 shares of Design Therapeutics Inc (DSGN) were sold and 4,118,715 shares were bought by its insiders, resulting in a net purchase of 4,118,715 shares.
Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Design Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does MoonLake Immunotherapeutics do?
Who are the key executives at MoonLake Immunotherapeutics?
Bihua Chen is the 10 percent owner of MoonLake Immunotherapeutics. Other key executives at MoonLake Immunotherapeutics include director & Chief Executive Officer Santos Da Silva Jorge , Chief Scientific Officer Kristian Reich , and Chief Financial Officer Matthias Bodenstedt .
MoonLake Immunotherapeutics (MLTX) Insider Trades Summary
Over the past 18 months, Bihua Chen made 4 insider transaction in MoonLake Immunotherapeutics (MLTX) with a net purchase of 1,629,151. Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net sale of 200,000 shares made by Kristian Reich , a net sale of 184,740 shares made by Santos Da Silva Jorge , and a net sale of 100,000 shares made by Matthias Bodenstedt .
In summary, during the past 3 months, insiders sold 384,740 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 384,740 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.
MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
MoonLake Immunotherapeutics Insider Transactions
- Download to Excel(.xls)
What does Monte Rosa Therapeutics Inc do?
Who are the key executives at Monte Rosa Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Monte Rosa Therapeutics Inc. Other key executives at Monte Rosa Therapeutics Inc include Principal Accounting Officer Edmund Dunn , General Counsel Philip Nickson , and Chief Business Officer Julian G Jones .
Monte Rosa Therapeutics Inc (GLUE) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monte Rosa Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does BioAtla Inc do?
Who are the key executives at BioAtla Inc?
Bihua Chen is the director & 10 percent owner of BioAtla Inc. Other key executives at BioAtla Inc include director & 10 percent owner & Chief Executive Officer Short Jay M Phd , See Remarks Christian Vasquez , and director & President Scott Andrew Smith .
BioAtla Inc (BCAB) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 15,700 shares made by Sylvia Mcbrinn , a net purchase of 90,800 shares made by Short Jay M Phd , and a net purchase of 27,495 shares made by Christian Vasquez .
In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 153,995 shares were bought by its insiders, resulting in a net purchase of 153,995 shares.
BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioAtla Inc Insider Transactions
- Download to Excel(.xls)
What does Vigil Neuroscience Inc do?
Who are the key executives at Vigil Neuroscience Inc?
Bihua Chen is the 10 percent owner of Vigil Neuroscience Inc. Other key executives at Vigil Neuroscience Inc include director & President and CEO Ivana Magovcevic-liebisch , Chief Medical Officer Christopher Silber , and Chief Science Officer Gray David L. F. .
Vigil Neuroscience Inc (VIGL) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Vigil Neuroscience Inc (VIGL). Other recent insider transactions involving Vigil Neuroscience Inc (VIGL) include a net purchase of 4,000 shares made by Ivana Magovcevic-liebisch , and a net sale of 300 shares made by Spyridon Papapetropoulos .
In summary, during the past 3 months, insiders sold 0 shares of Vigil Neuroscience Inc (VIGL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 300 shares of Vigil Neuroscience Inc (VIGL) were sold and 4,000 shares were bought by its insiders, resulting in a net purchase of 3,700 shares.
Vigil Neuroscience Inc (VIGL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vigil Neuroscience Inc Insider Transactions
- Download to Excel(.xls)
What does Biomea Fusion Inc do?
Who are the key executives at Biomea Fusion Inc?
Bihua Chen is the director & 10 percent owner of Biomea Fusion Inc. Other key executives at Biomea Fusion Inc include Chief Medical Officer Juan Pablo Frias , 10 percent owner A2a Pharmaceuticals, Inc. , and 10 percent owner Cormorant Asset Management, Lp .
Biomea Fusion Inc (BMEA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Biomea Fusion Inc (BMEA). Other recent insider transactions involving Biomea Fusion Inc (BMEA) include a net sale of 1,000,000 shares made by A2a Pharmaceuticals, Inc. , a net purchase of 400,000 shares made by Cormorant Global Healthcare Master Fund, Lp , and a net purchase of 5,000 shares made by Hitchcock Michael J.m. .
In summary, during the past 3 months, insiders sold 0 shares of Biomea Fusion Inc (BMEA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,000,000 shares of Biomea Fusion Inc (BMEA) were sold and 409,100 shares were bought by its insiders, resulting in a net sale of 590,900 shares.
Biomea Fusion Inc (BMEA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomea Fusion Inc Insider Transactions
- Download to Excel(.xls)
What does Verve Therapeutics Inc do?
Who are the key executives at Verve Therapeutics Inc?
Bihua Chen is the director & 10 percent owner of Verve Therapeutics Inc. Other key executives at Verve Therapeutics Inc include Chief Administrative Officer Joan Nickerson , director & 10 percent owner Krishna Yeshwant , and Chief Financial Officer Allison Dorval .
Verve Therapeutics Inc (VERV) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Verve Therapeutics Inc (VERV). Other recent insider transactions involving Verve Therapeutics Inc (VERV) include a net sale of 1,108 shares made by Allison Dorval , a net purchase of 1,800,000 shares made by Krishna Yeshwant , and a net sale of 1,514 shares made by Joan Nickerson .
In summary, during the past 3 months, insiders sold 1,514 shares of Verve Therapeutics Inc (VERV) in total and bought 0 shares, with a net sale of 1,514 shares. During the past 18 months, 3,487 shares of Verve Therapeutics Inc (VERV) were sold and 1,800,000 shares were bought by its insiders, resulting in a net purchase of 1,796,513 shares.
Verve Therapeutics Inc (VERV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Verve Therapeutics Inc Insider Transactions
- Download to Excel(.xls)
What does Ventyx Biosciences Inc do?
Who are the key executives at Ventyx Biosciences Inc?
Bihua Chen is the 10 percent owner of Ventyx Biosciences Inc. Other key executives at Ventyx Biosciences Inc include director & Chief Executive Officer Raju Mohan , Chief Financial Officer Martin Auster , and Chief Scientific Officer John Nuss .
Ventyx Biosciences Inc (VTYX) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Ventyx Biosciences Inc (VTYX). Other recent insider transactions involving Ventyx Biosciences Inc (VTYX) include a net sale of 1,349,712 shares made by Nsv Partners Iii Lp , a net sale of 1,349,712 shares made by Somu Subramaniam , and a net sale of 628,526 shares made by Raju Mohan .
In summary, during the past 3 months, insiders sold 9,019 shares of Ventyx Biosciences Inc (VTYX) in total and bought 0 shares, with a net sale of 9,019 shares. During the past 18 months, 4,237,062 shares of Ventyx Biosciences Inc (VTYX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,237,062 shares.
Ventyx Biosciences Inc (VTYX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ventyx Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Tyra Biosciences Inc do?
Who are the key executives at Tyra Biosciences Inc?
Bihua Chen is the 10 percent owner of Tyra Biosciences Inc. Other key executives at Tyra Biosciences Inc include Chief Operating Officer Daniel Bensen , director & Chief Executive Officer Todd Harris , and 10 percent owner Mva Investors, Llc .
Tyra Biosciences Inc (TYRA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Tyra Biosciences Inc (TYRA). Other recent insider transactions involving Tyra Biosciences Inc (TYRA) include a net sale of 276,298 shares made by Daniel Bensen , a net sale of 252,175 shares made by Todd Harris , and a net sale of 265,568 shares made by Mva Investors, Llc .
In summary, during the past 3 months, insiders sold 221,691 shares of Tyra Biosciences Inc (TYRA) in total and bought 0 shares, with a net sale of 221,691 shares. During the past 18 months, 794,041 shares of Tyra Biosciences Inc (TYRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 794,041 shares.
Tyra Biosciences Inc (TYRA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tyra Biosciences Inc Insider Transactions
- Download to Excel(.xls)
What does Kineta Inc do?
Who are the key executives at Kineta Inc?
Bihua Chen is the director & 10 percent owner of Kineta Inc. Other key executives at Kineta Inc include director & Chief Executive Officer Shawn Iadonato , President Craig W. Philips , and General Counsel Pauline Kenny .
Kineta Inc (KA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Kineta Inc (KA). Other recent insider transactions involving Kineta Inc (KA) include a net purchase of 12,301 shares made by Shawn Iadonato , a net purchase of 7,250 shares made by Raymond J. Bartoszek , and a net purchase of 4,397 shares made by Craig W. Philips .
In summary, during the past 3 months, insiders sold 0 shares of Kineta Inc (KA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,113 shares of Kineta Inc (KA) were sold and 50,250 shares were bought by its insiders, resulting in a net purchase of 44,137 shares.
Kineta Inc (KA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kineta Inc Insider Transactions
- Download to Excel(.xls)
What does Ambrx Biopharma Inc do?
Who are the key executives at Ambrx Biopharma Inc?
Bihua Chen is the 10 percent owner of Ambrx Biopharma Inc. Other key executives at Ambrx Biopharma Inc include 10 percent owner Cormorant Asset Management, Lp , Chief Financial Officer Sonja Nelson , and director & President and CEO Daniel J. O'connor .
Ambrx Biopharma Inc (AMAM) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Ambrx Biopharma Inc (AMAM). Other recent insider transactions involving Ambrx Biopharma Inc (AMAM) include a net purchase of 10,965,823 shares made by Cormorant Asset Management, Lp ,
In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ambrx Biopharma Inc (AMAM) were sold and 10,965,823 shares were bought by its insiders, resulting in a net purchase of 10,965,823 shares.
Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ambrx Biopharma Inc Insider Transactions
- Download to Excel(.xls)
What does GreenLight Biosciences Holdings PBC do?
Who are the key executives at GreenLight Biosciences Holdings PBC?
Bihua Chen is the other: See below of GreenLight Biosciences Holdings PBC. Other key executives at GreenLight Biosciences Holdings PBC include other: See remarks Mls Capital Fund Ii Lp , other: Member of 10% owner group Marta Ortega-valle , and other: Member of 13D Group Montealegre Lacayo Jaime Javier .
GreenLight Biosciences Holdings PBC (GRNA) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in GreenLight Biosciences Holdings PBC (GRNA). Other recent insider transactions involving GreenLight Biosciences Holdings PBC (GRNA) include a net sale of 9,188,659 shares made by Cormorant Global Healthcare Master Fund, Lp ,
In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.
GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.
GreenLight Biosciences Holdings PBC Insider Transactions
- Download to Excel(.xls)
What does Environmental Impact Acquisition Corp do?
Who are the key executives at Environmental Impact Acquisition Corp?
Bihua Chen is the other: See below of Environmental Impact Acquisition Corp. Other key executives at Environmental Impact Acquisition Corp include director & 10 percent owner Matthew Allen Walker , other: Member of 10% owner group Marta Ortega-valle , and other: Member of 13D Group Montealegre Lacayo Jaime Javier .
Environmental Impact Acquisition Corp (ENVIU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Environmental Impact Acquisition Corp Insider Transactions
- Download to Excel(.xls)
What does Ambrx Biopharma Inc do?
Who are the key executives at Ambrx Biopharma Inc?
Bihua Chen is the 10 percent owner of Ambrx Biopharma Inc. Other key executives at Ambrx Biopharma Inc include Chief Financial Officer Sonja Nelson , director & President and CEO Daniel J. O'connor , and 10 percent owner Cormorant Asset Management, Lp .
Ambrx Biopharma Inc (AMAM) Insider Trades Summary
Over the past 18 months, Bihua Chen made no insider transaction in Ambrx Biopharma Inc (AMAM). Other recent insider transactions involving Ambrx Biopharma Inc (AMAM) include a net purchase of 1,307,311 shares made by Cormorant Asset Management, Lp , a net sale of 50,012 shares made by Daniel J. O'connor , and a net sale of 12,778 shares made by Sonja Nelson .
In summary, during the past 3 months, insiders sold 0 shares of Ambrx Biopharma Inc (AMAM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 62,790 shares of Ambrx Biopharma Inc (AMAM) were sold and 1,307,311 shares were bought by its insiders, resulting in a net purchase of 1,244,521 shares.
Ambrx Biopharma Inc (AMAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ambrx Biopharma Inc Insider Transactions
- Download to Excel(.xls)
Bihua Chen Mailing Address
Above is the net worth, insider trading, and ownership report for Bihua Chen. You might contact Bihua Chen via mailing address: C/o Cormorant Asset Management, Lp, 200 Clarendon Street, 52nd Floor, Boston Ma 02116.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey